Profile data is unavailable for this security.
About the company
Jinan High-tech Development Co Ltd is a China-based company principally engaged in the in vitro diagnostics business. The Company operates three segments. The Real Estate and Property Services Business segment is mainly engaged in real estate development and sales and the provision of property and property leasing services. The In Vitro Diagnostics Business segment is mainly engaged in the research and development, production and sales of products such as molecular diagnostic reagents, molecular diagnostic automated testing equipment, biological sample library management software, biological sample intelligent storage cabinets, biological sample intelligent management terminals, and provides medical testing services. The products are mainly used in the fields of infectious disease prevention and control, pathogenic microorganism detection, food safety testing and other fields. The Other Business segment is mainly engaged in trading business and other businesses.
- Revenue in CNY (TTM)481.47m
- Net income in CNY-85.16m
- Incorporated1992
- Employees716.00
- LocationJinan High-tech Development Co Ltd3F,Sectn A,Jn Intl Cnvntn&Exbtn CtrNo. 1, Xinyu South RoadHigh-Tech Development ZoneJI'NAN 250101ChinaCHN
- Phone+86 53 186171188
- Fax+86 53 186171188
- Websitehttp://www.jhhg.net.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Hotgen Biotech Co Ltd | 520.50m | -67.64m | 2.98bn | 1.04k | -- | 0.9132 | -- | 5.72 | -0.7349 | -0.7349 | 5.74 | 35.25 | 0.1484 | 2.20 | 5.85 | 502,410.60 | -2.13 | 29.65 | -2.22 | 34.70 | 46.98 | 56.08 | -14.33 | 32.26 | 8.95 | -- | 0.0026 | 41.92 | -84.78 | 23.67 | -97.10 | -10.67 | 57.98 | -- |
| Hangzhou Biotest Biotech Co Ltd | 518.65m | 104.29m | 3.20bn | 629.00 | 30.27 | 1.35 | -- | 6.16 | 0.9897 | 0.9897 | 4.94 | 22.27 | 0.204 | 2.61 | 6.85 | 824,563.60 | 4.01 | 29.45 | 4.23 | 33.30 | 52.42 | 56.83 | 19.64 | 41.59 | 12.53 | -- | 0.0003 | 29.32 | -76.75 | 19.65 | -86.22 | 41.33 | 34.82 | -- |
| Shanghai General Hthy Info & Tech Co Ltd | 261.57m | 18.00m | 3.28bn | 355.00 | 182.35 | 3.06 | -- | 12.55 | 0.1324 | 0.1324 | 1.92 | 7.88 | 0.1908 | 1.16 | 0.5944 | 736,806.40 | 1.03 | 11.22 | 1.32 | 14.13 | 61.95 | 53.64 | 5.42 | 30.54 | 2.58 | -- | 0.1216 | 14.00 | -4.59 | 3.70 | -48.13 | -4.27 | 9.32 | -- |
| Shanghai Kindly Enterprise Dev Gp Co Ltd | 2.28bn | 209.26m | 3.33bn | 4.23k | 15.76 | 1.33 | -- | 1.46 | 0.4796 | 0.4796 | 5.24 | 5.68 | 0.5585 | 3.89 | 2.41 | 540,095.70 | 5.79 | 8.09 | 9.27 | 16.09 | 30.45 | 36.01 | 10.37 | 12.53 | 1.25 | -- | 0.1931 | 26.55 | -21.36 | 11.08 | -25.92 | 9.44 | 4.85 | 1.30 |
| Shanghai ZJ Bio-Tech Co Ltd | 206.71m | -184.51m | 3.43bn | 305.00 | -- | 0.908 | -- | 16.57 | -1.03 | -1.03 | 1.11 | 19.64 | 0.0507 | 0.1893 | 2.00 | 677,741.90 | -4.52 | 17.08 | -4.74 | 19.18 | 68.92 | 60.21 | -89.26 | 34.13 | 18.50 | -- | 0.0014 | 34.15 | -88.21 | 4.10 | -118.00 | -- | 35.93 | -- |
| Jinan High-tech Development Co Ltd | 481.47m | -85.16m | 3.49bn | 716.00 | -- | 19.83 | -- | 7.24 | -0.0963 | -0.0963 | 0.5443 | 0.1987 | 0.1754 | 0.5695 | 0.5716 | 672,442.60 | -4.12 | -2.99 | -22.80 | -9.42 | 16.01 | 30.52 | -23.48 | -10.84 | 0.5515 | -18.56 | 0.4291 | -- | -58.29 | -13.80 | -618.17 | -- | -35.45 | -- |
| Chimin Health Management Co Ltd | 899.55m | -82.14m | 3.89bn | 1.95k | -- | 2.53 | -- | 4.33 | -0.1882 | -0.1882 | 1.74 | 2.93 | 0.3562 | 3.93 | 4.91 | 462,018.90 | -3.05 | 1.54 | -3.90 | 2.41 | 40.56 | 44.32 | -8.58 | 4.05 | 1.24 | -3.66 | 0.2454 | 29.55 | 6.84 | 5.09 | -289.97 | -- | -10.57 | -- |
| Well Lead Medical Co Ltd | 1.47bn | 215.29m | 3.90bn | 2.62k | 17.97 | 2.12 | -- | 2.65 | 0.7402 | 0.7402 | 5.06 | 6.27 | 0.5762 | 4.68 | 7.77 | 561,039.90 | 8.81 | 8.25 | 10.56 | 10.17 | 44.37 | 43.45 | 15.29 | 13.04 | 1.49 | 239.62 | 0.2318 | 51.11 | 1.79 | 13.22 | 15.56 | 24.10 | 35.39 | 45.41 |
| SWS Hemodialysis Care Co Ltd | 532.45m | 74.82m | 3.96bn | 881.00 | 52.91 | 2.34 | -- | 7.44 | 0.233 | 0.233 | 1.66 | 5.27 | 0.2759 | 1.86 | 4.66 | 604,373.60 | 3.72 | -- | 4.02 | -- | 46.37 | -- | 13.47 | -- | 10.93 | -- | 0.016 | -- | 80.65 | -- | 228.34 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 67.60k | 0.01% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 11.50k | 0.00% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 4.40k | 0.00% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2024 | 3.80k | 0.00% |
| Harfor Fund Management Co., Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
